These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 1117777)
1. Infections in the immunosuppressed patient. O'Loughlin JM Med Clin North Am; 1975 Mar; 59(2):495-501. PubMed ID: 1117777 [TBL] [Abstract][Full Text] [Related]
2. Changing patterns of infections in the immunocompromised patient with cancer. Koll BS; Brown AE Hematol Oncol Clin North Am; 1993 Aug; 7(4):753-69. PubMed ID: 8354655 [TBL] [Abstract][Full Text] [Related]
3. The role of cellular and humoral factors in infections. Neu HC Clin Haematol; 1976 Jun; 5(2):449-65. PubMed ID: 780033 [No Abstract] [Full Text] [Related]
4. Prevention and treatment of cancer-related infections. Baden LR; Bensinger W; Angarone M; Casper C; Dubberke ER; Freifeld AG; Garzon R; Greene JN; Greer JP; Ito JI; Karp JE; Kaul DR; King E; Mackler E; Marr KA; Montoya JG; Morris-Engemann A; Pappas PG; Rolston K; Segal B; Seo SK; Swaminathan S; Naganuma M; Shead DA; J Natl Compr Canc Netw; 2012 Nov; 10(11):1412-45. PubMed ID: 23138169 [TBL] [Abstract][Full Text] [Related]
5. [Introduction to the clinical use of immunosuppressive agents]. Bach JF Ann Med Interne (Paris); 1974 Oct; 125(10):697-702. PubMed ID: 4548812 [No Abstract] [Full Text] [Related]
7. Infections in the immunocompromised host. Solberg CO Scand J Infect Dis Suppl; 1980; Suppl 24():36-43. PubMed ID: 6782661 [No Abstract] [Full Text] [Related]
8. [Virus infections during immunosuppression (author's transl)]. Goetz O MMW Munch Med Wochenschr; 1976 Apr; 118(17):541-4. PubMed ID: 818526 [TBL] [Abstract][Full Text] [Related]
9. Immunosuppression by chemical agents. Bach JF Transplant Proc; 1971 Mar; 3(1):27-33. PubMed ID: 4937894 [No Abstract] [Full Text] [Related]
10. Invasive fungal infection in the immunosuppressed host. Salit I; Hand R Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):267-76. PubMed ID: 1158537 [TBL] [Abstract][Full Text] [Related]
11. Microbiologic aspects in patients with leukemia. Bodey GP Hum Pathol; 1974 Nov; 5(6):687-98. PubMed ID: 4214167 [No Abstract] [Full Text] [Related]
12. Aggressive cancer treatment and its role in predisposing to infection. Tattersall MH Eur J Cancer (1965); 1975 Aug; 11suppl():9-19. PubMed ID: 815094 [No Abstract] [Full Text] [Related]
13. [The patient with impaired defense against infections. Types of defect and spectrum of infectious diseases]. Frøland SS Tidsskr Nor Laegeforen; 1983 Jan; 103(3):213-9. PubMed ID: 6687768 [No Abstract] [Full Text] [Related]
14. [Infections in immunosuppressed patients]. Valtonen V Duodecim; 1979; 95(23):1629-38. PubMed ID: 544237 [No Abstract] [Full Text] [Related]
16. Cell-mediated immunity and its role in resistance to infection. Wing EJ; Remington JS West J Med; 1977 Jan; 126(1):14-31. PubMed ID: 318786 [TBL] [Abstract][Full Text] [Related]
17. Infections in immunocompromised patients. I. Pathogenesis, etiology, and diagnosis. Klastersky J Clin Ther; 1985; 8(1):90-9. PubMed ID: 3914372 [TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immunity and resistance to infection: report of a WHO scientific group. World Health Organ Tech Rep Ser; 1973; 519():1-64. PubMed ID: 4634151 [No Abstract] [Full Text] [Related]
19. Infections in cancer patients. Bodey GP Cancer Treat Rev; 1975 Jun; 2(2):89-128. PubMed ID: 1102088 [No Abstract] [Full Text] [Related]